RE: Abbott, BlackRock & Novacyt13 Apr 2021 00:32
I've been a believer for sometime now that a takeover has been in the offing. All the reasons stated by Steve are valid.
Let's not forget, we don't seem to have sold that much in the US, maybe the results will provide some clarity on that BUT we should also rememeber the raft of PDMR share dealing carried out at the back end of last year including James Mccarthy buy below. He is sat of on quite a loss himself currently.
Makes you wonder, all those director buys and such poor forward guidance given not once but twice. Hammering the price and keeping it down.
Join the dots, a takeover is definitely coming imo.
Director/PDMR Shareholding
Paris, France and Camberley, UK - 13 November 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 13 November 2020, James McCarthy (PDMR), a corporate consultant, acquired 10,000 ordinary shares of €1/15 each in the Company at an average price of £8.953 per share. The resultant beneficial shareholding of Mr McCarthy is 10,000 ordinary shares representing 0.01% of the Company's issued share capital.